Press release
Anti-Infective Drugs Market Industry Size Analysis, Growth Insights, Opportunities Forecast 2021-2025
The Business Research Company
The global anti-infective drugs market is expected to decline from $132.16 billion in 2020 to $116.4 billion in 2021 at a compound annual growth rate (CAGR) of -11.9%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $158.29 billion in 2025 at a CAGR of 8%.
The Business Research Company offers "Anti-Infective Drugs Global Market Report 2021" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.
Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3604
The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites, and antiprotozoal agents to treat protozoan infections.
Some of the key players involved in the anti-infective drugs market are Gilead, Merck & Co, GlaxosmithKline, Bristol-Myers Squibb Company, Johnson & Johnson.
The countries covered in the global anti-infective drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global anti-infective drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Anti-Infective Drugs Market Segmentation:
1) By Type: Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report
A Few Points From The Table Of Content
1. Executive Summary
2.Report Structure
3.Anti-Infective Drugs Market Characteristics
4.Anti-Infective Drugs Market Product Analysis
5.Anti-Infective Drugs Market Supply Chain
……
20.Anti-Infective Drugs Market Competitive Landscape
21.Key Mergers And Acquisitions In The Anti-Infective Drugs Market
22. Market Background: Pharmaceutical Drugs Market
23.Recommendations
24.Appendix
25.Copyright And Disclaimer
The report covers the trends and market dynamics of the anti-infective drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample Copy of this report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3604
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow our blog: http://blog.tbrc.info/
About Us:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Infective Drugs Market Industry Size Analysis, Growth Insights, Opportunities Forecast 2021-2025 here
News-ID: 2246878 • Views: …
More Releases from The Business research company
Power MOSFET (Metal-Oxide-Semiconductor Field-Effect Transistor) Market Opportun …
The power mosfet (metal-oxide-semiconductor field-effect transistor) market size has grown strongly in recent years. It will grow from $7.6 billion in 2023 to $8.22 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to proliferation of electronics in consumer devices, growth in power electronics applications, increasing demand for energy-efficient devices, expansion of the automotive industry, evolving telecommunications…
Pharmaceutical Fluid Handling Market Revenue, Segmentation, Future Growth Prospe …
The pharmaceutical fluid handling market size has grown steadily in recent years. It will grow from $11.24 billion in 2023 to $11.78 billion in 2024 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to regulatory standards and compliance, technology integration, quality control emphasis, innovation in drug delivery, laboratory automation.
The pharmaceutical fluid handling market size is expected to see strong…
Brake Caliper Market Research Report 2024-2033 | Size, Share Analysis And Strate …
The brake caliper market size has grown steadily in recent years. It will grow from $11.39 billion in 2023 to $11.96 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to automotive safety regulations, evolution in automotive design, demand for performance vehicles, improved manufacturing processes, automotive performance enhancement.
The brake caliper market size is expected to see…
Warts Therapeutics Market Outlook, Opportunities, and Strategies 2024-2033: Stra …
The warts therapeutics market size has grown steadily in recent years. It will grow from $1.91 billion in 2023 to $1.98 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to salicylic acid use, cryotherapy development, topical treatments evolution, surgical interventions, emergence of immunotherapy.
The warts therapeutics market size is expected to see steady growth in the…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
